Kerry D. Ingalls - Net Worth and Insider Trading
Kerry D. Ingalls Net Worth
The estimated net worth of Kerry D. Ingalls is at least $157,300 dollars as of 2024-08-26. Kerry D. Ingalls is the COO of Poseida Therapeutics Inc and owns about 55,000 shares of Poseida Therapeutics Inc (PSTX) stock worth over $157,300. Details can be seen in Kerry D. Ingalls's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kerry D. Ingalls has not made any transactions after 2022-03-16 and currently still holds the listed stock(s).
Transaction Summary of Kerry D. Ingalls
Kerry D. Ingalls Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kerry D. Ingalls owns 1 companies in total, including Poseida Therapeutics Inc (PSTX) .
Click here to see the complete history of Kerry D. Ingalls’s form 4 insider trades.
Insider Ownership Summary of Kerry D. Ingalls
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTX | Poseida Therapeutics Inc | 2022-03-16 | Chief Operating Officer |
Kerry D. Ingalls Latest Holdings Summary
Kerry D. Ingalls currently owns a total of 1 stock. Kerry D. Ingalls owns 55,000 shares of Poseida Therapeutics Inc (PSTX) as of March 16, 2022, with a value of $157,300.
Latest Holdings of Kerry D. Ingalls
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PSTX | Poseida Therapeutics Inc | 2022-03-16 | 55,000 | 2.86 | 157,300 |
Holding Weightings of Kerry D. Ingalls
Kerry D. Ingalls Form 4 Trading Tracker
According to the SEC Form 4 filings, Kerry D. Ingalls has made a total of 2 transactions in Poseida Therapeutics Inc (PSTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Poseida Therapeutics Inc is the acquisition of 3,000 shares on March 16, 2022, which cost Kerry D. Ingalls around $11,940.
Insider Trading History of Kerry D. Ingalls
- 1
Kerry D. Ingalls Trading Performance
GuruFocus tracks the stock performance after each of Kerry D. Ingalls's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kerry D. Ingalls is -49.65%. GuruFocus also compares Kerry D. Ingalls's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kerry D. Ingalls within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kerry D. Ingalls's insider trading performs compared to the benchmark.
Performance of Kerry D. Ingalls
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.77 | | | | | |
| Relative Return to S&P 500(%) | -0.45 | | | | | |
Kerry D. Ingalls Ownership Network
Kerry D. Ingalls Owned Company Details
What does Poseida Therapeutics Inc do?
Who are the key executives at Poseida Therapeutics Inc?
Kerry D. Ingalls is the Chief Operating Officer of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include President & Cell Therapy Kristin Yarema , 10 percent owner Malin Life Sciences Holdings Ltd , and director & 10 percent owner & Chief Executive Officer Eric Ostertag .
Poseida Therapeutics Inc (PSTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Poseida Therapeutics Inc Insider Transactions
Kerry D. Ingalls Mailing Address
Above is the net worth, insider trading, and ownership report for Kerry D. Ingalls. You might contact Kerry D. Ingalls via mailing address: C/o Poseida Therapeutics, Inc., 9390 Towne Centre Drive, Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
